Belgium's medicines paradox: pharma giant, but a desert for new drugs

17-06-2026

EURACTIV - Belgium ranks among the European leaders in pharmaceutical research, patents, exports and jobs. Yet only half of the innovative medicines approved at the European level between 2021 and 2024 are available to Belgian patients, and those that do arrive take on average a year and a half. Read more